# Study of AT-587 in Healthy Subjects

> **NCT07728487** · PHASE1 · RECRUITING · sponsor: **Atea Pharmaceuticals, Inc.** · enrollment: 62 (estimated)

## Conditions studied

- Hepatitis E

## Interventions

- **DRUG:** AT-587
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07728487
- **Lead sponsor:** Atea Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-13
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07728487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07728487, "Study of AT-587 in Healthy Subjects". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07728487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*